estrone-3-glucuronide has been researched along with mifepristone in 5 studies
| Studies (estrone-3-glucuronide) | Trials (estrone-3-glucuronide) | Recent Studies (post-2010) (estrone-3-glucuronide) | Studies (mifepristone) | Trials (mifepristone) | Recent Studies (post-2010) (mifepristone) |
|---|---|---|---|---|---|
| 191 | 18 | 21 | 6,536 | 595 | 1,758 |
| Protein | Taxonomy | estrone-3-glucuronide (IC50) | mifepristone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Canis lupus familiaris (dog) | 0.0264 | |
| Bile salt export pump | Homo sapiens (human) | 2.02 | |
| Estrogen receptor | Homo sapiens (human) | 4.311 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.0249 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0003 | |
| Progesterone receptor | Homo sapiens (human) | 0.1347 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.774 | |
| Glucocorticoid receptor | Mus musculus (house mouse) | 0.0022 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 2.0938 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 9.5 | |
| Coagulation factor VII | Homo sapiens (human) | 0.0003 | |
| Androgen receptor | Homo sapiens (human) | 0.2988 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 1.5 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 4.9 | |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Rattus norvegicus (Norway rat) | 0.0016 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.555 | |
| Tissue factor | Homo sapiens (human) | 0.0003 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0083 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0014 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0022 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0078 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.457 | |
| Estrogen receptor beta | Homo sapiens (human) | 1.528 | |
| Glucocorticoid receptor | Sus scrofa (pig) | 0.0153 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baird, DT; Hillier, H; Ledger, WL; Sweeting, VM | 1 |
| Bygdeman, M; Daniore, V; de la Torre, B; Johannisson, E; Swahn, ML | 1 |
| Croxatto, HB; Romero, C; Salvatierra, AM; Spitz, IM | 1 |
| Baulieu, EE; Kettel, LM; Morales, AJ; Murphy, AA; Ulmann, A; Yen, SS | 1 |
| Baird, DT; Glasier, AF; Hapangama, DK | 1 |
1 trial(s) available for estrone-3-glucuronide and mifepristone
| Article | Year |
|---|---|
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
Topics: Adolescent; Adult; Endometriosis; Estrone; Female; Hormone Antagonists; Humans; Luteinizing Hormone; Mifepristone; Progesterone; Prospective Studies | 1996 |
4 other study(ies) available for estrone-3-glucuronide and mifepristone
| Article | Year |
|---|---|
Inhibition of ovulation by low-dose mifepristone (RU 486).
Topics: Adult; Estrogens, Conjugated (USP); Estrone; Female; Humans; Luteinizing Hormone; Mifepristone; Ovulation; Pituitary Hormones; Pituitary-Adrenal System; Pregnanediol; Steroids | 1992 |
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Topics: Adult; Endometrium; Estrenes; Estrone; Female; Humans; Hydrocortisone; Luteinizing Hormone; Menstrual Cycle; Menstruation; Menstruation-Inducing Agents; Middle Aged; Mifepristone; Pregnanediol | 1988 |
Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Topics: Adult; Estradiol; Estrenes; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteal Phase; Luteinizing Hormone; Menstruation; Mifepristone; Ovulation; Pregnanediol; Progesterone | 1987 |
Noncompliance among a group of women using a novel method of contraception.
Topics: Cohort Studies; Contraceptives, Oral, Synthetic; Estrone; Family Planning Services; Female; Humans; Luteinizing Hormone; Mifepristone; Ovulation Detection; Progesterone; Prospective Studies; Statistics, Nonparametric; Treatment Refusal | 2001 |